Henan Lingrui Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 788.65 million compared to CNY 682.12 million a year ago. Revenue was CNY 788.65 million compared to CNY 682.12 million a year ago.

Net income was CNY 144.25 million compared to CNY 130.77 million a year ago. Basic earnings per share from continuing operations was CNY 0.26 compared to CNY 0.237 a year ago. Diluted earnings per share from continuing operations was CNY 0.254 compared to CNY 0.229 a year ago.